Nasacort AQ Nasal spray 55 mcg/dose 120 sprays
Sanofi Egypt
Sanofi Egypt
Composition
Active ingredient
Triamcinolone acetonide 55 mcg per dose.
Excipients
Microcrystalline cellulose, carmellose sodium, polysorbate 80, purified water, anhydrous glucose, benzalkonium chloride, disodium edetate, hydrochloric acid or sodium hydroxide.
Description
Nasacort AQ is a corticosteroid nasal spray used to treat symptoms of allergic rhinitis.
It reduces inflammation, swelling, and nasal congestion.
Indications for Use
Symptomatic treatment of allergic rhinitis in adults and children aged 2 years and older:
Nasal congestion.
Sneezing.
Runny nose.
Itchy nose.
Seasonal and perennial allergies.
Dosage and Administration
Adults and children over 12 years: 2 sprays in each nostril once daily.
Reduce to 1 spray when controlled.
Children 6-12 years: 1 spray in each nostril once daily.
May increase to 2 sprays if needed.
Children 2-5 years: 1 spray in each nostril once daily.
Shake before use.
Contraindications
Hypersensitivity to ingredients.
Children under 2 years.
Precautions
Consult a doctor before use if
Nasal infection present.
Recent nasal surgery or injury.
Glaucoma or cataracts.
Switching from systemic steroids.
Benzalkonium chloride may cause nasal irritation.
Side Effects
Common
Runny nose.
Headache.
Nosebleeds.
Sore throat.
Possible
Nasal dryness and irritation.
Taste/smell changes.
Nausea.
Sleep disturbance.
Cataracts or glaucoma.
Rare
Allergic reactions.
Pregnancy and Breastfeeding
Use only after medical advice.
Storage Conditions
Store below 25°C.
Keep out of reach of children.
Discard within 2 months after opening.
Packaging
A carton box containing a plastic nasal spray bottle with pump delivering at least 120 sprays.